Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Mileshkin

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
Trials|February 13, 2013
A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trialPenelope Schofield, Ilona Juraskova, Rebecca Bergin, et al.
Journal of Palliative Medicine|March 5, 2014
Acceptability of early integration of palliative care in patients with incurable lung cancerBrian H C Le, Linda Mileshkin, Katie Doan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 16, 2014
Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedsideJeremy Lewin, Carleen Cullinane, Tim Akhurst, et al.
British Journal of Cancer|December 21, 2021
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumoursJason D Lickliter, Mark Voskoboynik, Linda Mileshkin, et al.
Pilot and Feasibility Studies|March 28, 2019
A randomised phase II trial to examine feasibility of standardised, early palliative (STEP) care for patients with advanced cancer and their families [ACTRN12617000534381]: a research protocolJennifer Philip, Anna Collins, Brian Le, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2026
Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapyJulianne O'Shea, Kelvin Yu, David Chang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2025
Erratum to 'Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]Andreas Obermair, Val Gebski, Jeffrey Goh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2025
Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinomaAndreas Obermair, Val Gebski, Jeffrey Goh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment optionLinda Mileshkin, Penelope E Schofield, Michael Jefford, et al.
Journal of Geriatric Oncology|September 30, 2025
Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignanciesAdel Shahnam, Nadia Hitchen, Sathya Manoharan, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Trials|February 13, 2013
A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trialPenelope Schofield, Ilona Juraskova, Rebecca Bergin, et al.
Journal of Palliative Medicine|March 5, 2014
Acceptability of early integration of palliative care in patients with incurable lung cancerBrian H C Le, Linda Mileshkin, Katie Doan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 16, 2014
Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedsideJeremy Lewin, Carleen Cullinane, Tim Akhurst, et al.
British Journal of Cancer|December 21, 2021
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumoursJason D Lickliter, Mark Voskoboynik, Linda Mileshkin, et al.
Pilot and Feasibility Studies|March 28, 2019
A randomised phase II trial to examine feasibility of standardised, early palliative (STEP) care for patients with advanced cancer and their families [ACTRN12617000534381]: a research protocolJennifer Philip, Anna Collins, Brian Le, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2026
Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapyJulianne O'Shea, Kelvin Yu, David Chang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2025
Erratum to 'Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]Andreas Obermair, Val Gebski, Jeffrey Goh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2025
Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinomaAndreas Obermair, Val Gebski, Jeffrey Goh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment optionLinda Mileshkin, Penelope E Schofield, Michael Jefford, et al.
Journal of Geriatric Oncology|September 30, 2025
Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignanciesAdel Shahnam, Nadia Hitchen, Sathya Manoharan, et al.
Pageof 18